Abstract:Background and Aims Osteopontin (OPN) promotes the ductular reaction and is a major driver of chronic liver disease (CLD) progression. Although CLD is characterised by the accumulation of inflammatory cells including macrophages around the peri‐portal regions, the influence of OPN on recruitment is unclear. We investigated the role of OPN in cholangiocyte chemokine production and macrophage recruitment by combining in vivo, in vitro, and in silico approaches. Methods The effects of OPN on cholangiocyte chemokine production and macrophage migration were assessed in culture, alongside RNA‐sequencing to identify genes and pathways affected by OPN depletion. Murine liver injury models were used to assess liver chemokine expression and liver macrophage/monocyte recruitment. OPN and chemokine expression were analysed in liver tissue and plasma from biopsy‐proven metabolic dysfunction‐associated alcoholic steatohepatitis (MASH) patients. Results OPN‐knockdown in cholangiocytes reduced chemokine secretion. RNA‐sequencing showed OPN‐related effects clustered around immunity, chemotaxis and chemokine production. Macrophage exposure to cholangiocyte‐conditioned media showed OPN‐supported migration via chemokines chemokine (C‐C motif) ligand (CCL)2, CCL5 and chemokine (C‐X‐C motif) ligand (CXCL)1. These effects were related to NF‐κB signalling. Murine liver fibrosis was accompanied by upregulated liver OPN, CCL2, CCL5 and CXCL1 mRNA, and accumulation of liver cluster of differentiation (CD)11b/F4/80+CC chemokine receptors (CCR2)high macrophages but treatment with OPN‐specific neutralising aptamers reduced fibrosis, chemokine mRNAs and accumulation of liver CD11b/F4/80+CCR2high/lymphocyte antigen 6 complexhigh inflammatory monocytes. In human MASH, liver OPN correlated with chemokines CCL2 and IL8 in association with portal injury and fibrosis. Plasma OPN, serum CCL2 and IL8 also increased with fibrosis stage. Conclusions OPN promotes cholangiocyte chemokine secretion and the accumulation of pro‐inflammatory monocytes. These data support neutralisation of OPN as an anti‐inflammatory and anti‐fibrotic strategy.

Osteopontin As a Mediator of NKT Cell Function in T Cell-Mediated Liver Diseases.

Osteopontin Regulates Development And Function Of Invariant Natural Killer T Cells

Osteopontin Small Interfering RNA Protects Mice from Fulminant Hepatitis.

Osteopontin Affects the Persistence of Beta-Glucan-induced Hepatic Granuloma Formation and Tissue Injury Through Two Distinct Mechanisms.

Osteopontin Regulates Interleukin-17 Production in Hepatitis

Osteopontin Acts As a Negative Regulator of Autophagy Accelerating Lipid Accumulation During the Development of Nonalcoholic Fatty Liver Disease

Osteopontin Promotes Dendritic Cell Maturation and Function in Response to HBV Antigens

The Expression and Clinical Relevation of Osteopontin and IL-17 in Severe Hepatitis B

Role Of Osteopontin In Liver Diseases

Osteopontin Takes Center Stage in Chronic Liver Disease

Natural Killer T Cells Play a Necessary Role in Modulating of Immune-Mediated Liver Injury by Gut Microbiota

Syndecan-4 protects against osteopontin-mediated acute hepatic injury by masking functional domains of osteopontin.

Thrombin Cleavage of Osteopontin Controls Activation of Hepatic Stellate Cells and is Essential for Liver Fibrogenesis

Osteopontin: an important molecule in liver diseases

Lamina Propria Interleukin 17 A Aggravates Natural Killer T-cell Activation in Autoimmune Hepatitis

Osteopontin Contributes to TGF-β1 Mediated Hepatic Stellate Cell Activation

Osteopontin expression is essential for interferon-α production by plasmacytoid dendritic cells

Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells.

Osteopontin Promotes Cholangiocyte Secretion of Chemokines to Support Macrophage Recruitment and Fibrosis in MASH

Osteopontin: A Key Regulator of Tumor Progression and Immunomodulation

Enterogenous Bacterial Glycolipids Are Required for the Generation of Natural Killer T Cells Mediated Liver Injury